From February 5, 2024 to March 31, 2024, the company has repurchased 4,445,000 shares, representing 0.69% for CNY 30.1 million. With this, the company has completed the repurchase of 4,445,000 shares, representing 0.69% for CNY 30.1 million under the buyback announced on February 6, 2024.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.51 CNY | -2.98% | +3.99% | -30.30% |
04-26 | Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-24 | Guangdong Hybribio Biotech Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.30% | 578M | |
-1.29% | 12.64B | |
-0.47% | 8.46B | |
+5.68% | 5.66B | |
+22.61% | 5.27B | |
-2.03% | 4.49B | |
-53.56% | 3.11B | |
+19.30% | 2.87B | |
+33.07% | 2.31B | |
-8.42% | 2.23B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.